Restriction Spectrum Imaging as a quantitative biomarker for prostate cancer with reliable positive predictive value. Domingo MR, Do DD, Conlin CC, Bagrodia A, et al. J Urol 2025 May 16:101097JU0000000000004611. doi: 10.1097/JU.0000000000004611.

Read + Share

Amedeo Smart

Independent Medical Education

Domingo MR, Do DD, Conlin CC, Bagrodia A, et al. Restriction Spectrum Imaging as a quantitative biomarker for prostate cancer with reliable positive predictive value. J Urol 2025 May 16:101097JU0000000000004611. doi: 10.1097/JU.0000000000004611.
PMID: 40377262